Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors

Biotechnology and Bioengineering

Volumn 112, Issue 10, 2015, Pages 1967-1983

  Frazier, Nick ^a,b   Ghandehari, Hamidreza ^a,b  

^a University of Utah   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Cancer; Drug delivery; Hyperthermia; Nanomedicine

Indexed keywords

DRUG DELIVERY; NANOPARTICLES; TUMORS;

ACTIVE TARGETING; CANCER; CELLULAR MECHANISMS; COMBINATION EFFECTS; DIFFERENT MECHANISMS; DRUG DELIVERY SYSTEM; HYPERTHERMIA; NANOMEDICINES;

MEDICAL NANOTECHNOLOGY;

GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOCAGE; NANOPARTICLE; NANOROD; NANOSHELL; ANTINEOPLASTIC AGENT; DRUG CARRIER; NANOMATERIAL;

CANCER THERAPY; DRUG DELIVERY SYSTEM; ELECTROMAGNETIC RADIATION; HEAT; HEAT TOLERANCE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYPERTHERMIA; MICROWAVE RADIATION; NANOMEDICINE; NONHUMAN; REVIEW; SOLID TUMOR; ANIMAL; NEOPLASMS; PROCEDURES; THERMOTHERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; HUMANS; HYPERTHERMIA, INDUCED; NANOMEDICINE; NANOSTRUCTURES; NEOPLASMS;

EID: 84939807833     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25653     Document Type: Review

References (172)

1. Allen TM, Cullis PR. 2013. Liposomal drug delivery systems: From concept to clinical applications. Adv Drug Deliv Rev 65(1):36-48.
2. Babincová M, Altanerová V, Lampert M, Altaner C, Machová E, Srámka M, Babinec P. 2000. Site-specific in vivo targeting of magnetoliposomes using externally applied magnetic field. Z Naturforsch [C] 55(3-4):278-281.
3. Babincová M, Čičmanec P, Altanerová V, Altaner Č, Babinec P. 2002. AC-magnetic field controlled drug release from magnetoliposomes: Design of a method for site-specific chemotherapy. Bioelectrochemistry 55(1-2):17-19.
4. Bae YH, Mrsny RJ, Park K. 2013. Cancer targeted drug delivery: An elusive dream. New York: Springer Science & Business Media.
5. Bae YH, Park K. 2011. Targeted drug delivery to tumors: Myths, reality and possibility. J Control Release 153(3):198.
6. Baluk P, Hashizume H, McDonald DM. 2005. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15(1):102-111.
7. Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T, Tan W. 2012. Nanotechnology in therapeutics: A focus on nanoparticles as a drug delivery system. Nanomedicine 7(8):1253-1271.
8. Blanco E, Kessinger CW, Sumer BD, Gao J. 2009. Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med 234(2):123-131.
9. Brazel CS 2009. Magnetothermally-responsive nanomaterials: Combining magnetic nanostructures and thermally-sensitive polymers for triggered drug release. Pharm Res 26(3):644-656.
10. Buckway B, Frazier N, Gormley AJ, Ray A, Ghandehari H. 2014. Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors. Nucl Med Biol 41(3):282-289.
11. Burke AR, Singh RN, Carroll DL, Wood JCS, D'Agostino RB Jr., Ajayan PM, Torti FM, Torti SV. 2012. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials 33(10):2961-2970.
12. Byrne JD, Betancourt T, Brannon-Peppas L. 2008. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60(15):1615-1626.
13. Campbell RB, Fukumura D, Brown EB, Mazzola LM, Izumi Y, Jain RK, Torchilin VP, Munn LL. 2002. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res 62(23):6831-6836.
14. Canal F, Sanchis J, Vicent MJ. 2011. Polymer-drug conjugates as nano-sized medicines. Curr Opin Biotechnol 22(6):894-900.
15. Celsion. 2015a. Analysis of 285 patient subgroup shows an impressive statistically significant 59% improvement in overall survival results at two years post treatment continue to support protocol for ongoing Phase III OPTIMA trial. http://investor.celsion.com/releasedetail.cfm?ReleaseID=897613. Accessed April 23, 2015.
16. Celsion. 2015b. ThermoDox® continues to demonstrate impressive local response rate in highly refractory patients company to initiate Euro-DIGNITY Trial this quarter European Early Access Program set to launch this month. http://investor.celsion.com/releasedetail.cfm?ReleaseID=906654. Accessed April 23, 2015.
17. Chabner BA, Longo DL. 2011. Cancer chemotherapy and biotherapy: Principles and practice. Philadelphia: Lippincott Williams & Wilkins.
18. Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK. 2011. Delivery of molecular and nanoscale medicine to tumors: Transport barriers and strategies. Ann Rev Chem Biomol Eng 2(1):281-298.
19. Chelvi PT, Jain SK, Ralhan R. 1995. Heat-mediated selective delivery of liposomeassociated melphalan in murine melanoma. Melanoma Res 5(5):321-326.
20. Chen J, Glaus C, Laforest R, Zhang Q, Yang M, Gidding M, Welch MJ, Xia Y. 2010. Gold nanocages as photothermal transducers for cancer treatment. Small 6(7):811-817.
21. Chen J, Wang D, Xi J, Au L, Siekkinen A, Warsen A, Li Z-Y, Zhang H, Xia Y, Li X. 2007. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 7(5):1318-1322.
22. Chen J, Wiley B, Li ZY, Campbell D, Saeki F, Cang H, Au L, Lee J, Li X, Xia Y. 2005. Gold nanocages: Engineering their structure for biomedical applications. Adv Mater 17(18):2255-2261.
23. Chen L, Li L, Zhang H, Liu W, Yang Y, Liu X, Xu B. 2014. Magnetic thermosensitive core/shell microspheres: Synthesis, characterization and performance in hyperthermia and drug delivery. RSC Adv 4(87):46806-46812.
24. Chicheł A, Skowronek J, Kubaszewska M, Kanikowski M. 2007. Hyperthermia-Description of a method and a review of clinical applications. Rep Pract Oncol Radiother 12(5):267-275.
25. Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S. 2014. When do changes in cancer survival mean progress? The insight from population incidence and mortality. JNCI Monogr 2014(49):187-197.
26. Chuanqian Z, Johnson DT, Brazel CS. 2008. Numerical study on the multi-region bio-heat equation to model magnetic fluid hyperthermia (MFH) using low curie temperature nanoparticles. IEEE Trans Nanobioscience 7(4):267-275.
27. de Smet M, Heijman E, Langereis S, Hijnen NM, Grüll H. 2011. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: An in vivo proof-of-concept study. J Control Release 150(1):102-110.
28. Dicheva BM, ten Hagen TLM, Schipper D, Seynhaeve ALB, van Rhoon GC, Eggermont AMM, Koning GA. 2014. Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes. J Control Release 195(10):37-48.
29. Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF, El-Sayed MA. 2008. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 269(1):57-66.
30. Dreher MR, Liu W, Michelich CR, Dewhirst MW, Chilkoti A. 2007. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res 67(9):4418-4424.
31. Dromi S, Frenkel V, Luk A, Traughber B, Angstadt M, Bur M, Poff J, Xie J, Libutti SK, Li KCP, Wood BJ. 2007. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res 13(9):2722-2727.
32. Duncan B, Kim C, Rotello VM. 2010. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release 148(1):122-127.
33. Duncan R. 2003. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2(5):347-360.
34. Duncan R. 2011. Polymer therapeutics as nanomedicines: New perspectives. Curr Opin Biotechnol 22(4):492-501.
35. Elsadek B, Kratz F. 2012. Impact of albumin on drug delivery-New applications on the horizon. J Control Release 157(1):4-28.
36. Falk MHIRD. 2001. Hyperthermia in oncology. Int J Hyperthermia 17(1):1-18.
37. Fenske DB, Chonn A, Cullis PR. 2008. Liposomal nanomedicines: An emerging field. Toxicol Pathol 36(1):21-29.
38. Fenske DB, Cullis PR. 2007. Liposomal nanomedicines. Expert Opin Drug Deliv 5(1):25-44.
39. Filippousi M, Altantzis T, Stefanou G, Betsiou M, Bikiaris DN, Angelakeris M, Pavlidou E, Zamboulis D, Van Tendeloo G. 2013. Polyhedral iron oxide core-shell nanoparticles in a biodegradable polymeric matrix: Preparation, characterization and application in magnetic particle hyperthermia and drug delivery. RSC Adv 3(46):24367-24377.
40. Fry FJ. 1958. Precision high intensity focusing ultrasonic machines for surgery. Am J Phys Med Rehabil 37(3):152-156.
41. Fu G, Liu W, Feng S, Yue X. 2012. Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy. Chem Commun 48(94):11567-11569.
42. Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y. 1994. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54(4):987-992.
43. Gasselhuber A, Dreher MR, Rattay F, Wood BJ, Haemmerich D. 2012. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model. PLoS ONE 7(10):e47453.
44. Ghosh P, Han G, De M, Kim CK, Rotello VM. 2008. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 60(11):1307-1315.
45. Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. 2007. Near-Infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 7(7):1929-1934.
46. Goel S, Chen F, Cai W. 2014. Synthesis and biomedical applications of copper sulfide nanoparticles: From sensors to theranostics. Small 10(4):631-645.
47. Gonzales M, Krishnan KM. 2005. Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia. J Magn Magn Mater 293(1):265-270.
48. Gormley AJ, Greish K, Ray A, Robinson R, Gustafson JA, Ghandehari H. 2011a. Gold nanorod mediated plasmonic photothermal therapy: A tool to enhance macromolecular delivery. Int J Pharm 415(1-2):315-318.
49. Gormley AJ, Larson N, Banisadr A, Robinson R, Frazier N, Ray A, Ghandehari H. 2013. Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers. J Control Release 166(2):130-138.
50. Gormley AJ, Larson N, Sadekar S, Robinson R, Ray A, Ghandehari H. 2012. Guided delivery of polymer therapeutics using plasmonic photothermal therapy. Nano Today 7(3):158-167.
51. Gormley AJ, Malugin A, Ray A, Robinson R, Ghandehari H. 2011b. Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment. J Drug Target 19(10):915-924.
52. Gossner L, May A, Stolte M, Seitz G, Hahn EG, Ell C. 1999. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 49(1):8-12.
53. Grüll H, Langereis S. 2012. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release 161(2):317-327.
54. Guo L, Yan DD, Yang D, Li Y, Wang X, Zalewski O, Yan B, Lu W. 2014. Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles. ACS Nano 8(6):5670-5681.
55. Haag R, Kratz F. 2006. Polymer therapeutics: Concepts and applications. Angew Chem Int Ed 45(8):1198-1215.
56. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. 2000. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156(4):1363-1380.
57. Hauck TS, Jennings TL, Yatsenko T, Kumaradas JC, Chan WCW. 2008. Enhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermia. Adv Mater 20(20):3832-3838.
58. Hergt R, Andra W, d'Ambly CG, Hilger I, Kaiser WA, Richter U, Schmidt HG. 1998. Physical limits of hyperthermia using magnetite fine particles. IEEE Trans Magn 34(5):3745-3754.
59. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. 2002. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43(1):33-56.
60. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL. 2003. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci 100(23):13549-13554.
61. Hoffman HA, Chakrabarti L, Dumont MF, Sandler AD, Fernandes R. 2014. Prussian blue nanoparticles for laser-induced photothermal therapy of tumors. RSC Adv 4(56):29729-29734.
62. Hu M, Chen J, Li Z-Y, Au L, Hartland GV, Li X, Marquez M, Xia Y. 2006a. Gold nanostructures: Engineering their plasmonic properties for biomedical applications. Chem Soc Rev 35(11):1084-1094.
63. Hu M, Petrova H, Chen J, McLellan JM, Siekkinen AR, Marquez M, Li X, Xia Y, Hartland GV. 2006b. Ultrafast laser studies of the photothermal properties of gold nanocages. J Phys Chem B 110(4):1520-1524.
64. Huang X, El-Sayed IH, Qian W, El-Sayed MA. 2006. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128(6):2115-2120.
65. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. 2008. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 23:217-228.
66. Huff TB, Tong L, Zhao Y, Hansen MN, Cheng J-X, Wei A. 2007. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine 2(1):125-132.
67. Hynynen K. 2011. MRIgHIFU: A tool for image-guided therapeutics. J Magn Reson Imaging 34(3):482-493.
68. Hynynen K, Freund WR, Cline HE, Chung AH, Watkins RD, Vetro JP, Jolesz FA. 1996. A clinical, noninvasive, MR imaging-monitored ultrasound surgery method. Radiographics 16(1):185-195.
69. Ito A, Shinkai M, Honda H, Kobayashi T. 2005. Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100(1):1-11.
70. Jain S, Hirst DG, O'Sullivan JM. 2012. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 85(1010):101-113.
71. Jang B, Kim YS, Choi Y. 2011. Effects of gold nanorod concentration on the depth-related temperature increase during hyperthermic ablation. Small 7(2):265-270.
72. Jordan A, Scholz R, Wust P, Fähling H, Roland F. 1999. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 201(1-3):413-419.
73. Kampinga HH. 2006. Cell biological effects of hyperthermia alone or combined with radiation or drugs: A short introduction to newcomers in the field. Int J Hyperthermia 22(3):191-196.
74. Kappiyoor R, Liangruksa M, Ganguly R, Puri IK. 2010. The effects of magnetic nanoparticle properties on magnetic fluid hyperthermia. J Appl Phys 108(9):094702-094702-8.
75. Khandhar AP, Ferguson RM, Simon JA, Krishnan KM. 2012. Enhancing cancer therapeutics using size-optimized magnetic fluid hyperthermia. J Appl Phys 111(7):07B306-07B306-3.
76. Khokhlova TD, Hwang JH. 2011. HIFU for palliative treatment of pancreatic cancer. J Gastrointest Oncol 2(3):175-184.
77. Kirui DK, Koay EJ, Guo X, Cristini V, Shen H, Ferrari M. 2014. Tumor vascular permeabilization using localized mild hyperthermia to improve macromolecule transport. Nanomedicine 10(7):1487-1496.
78. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. 2000. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 60(24):6950-6957.
79. Kong G, Braun RD, Dewhirst MW. 2001. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 61(7):3027-3032.
80. Koning GA, Eggermont AM, Lindner LH, ten Hagen TL. 2010. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res 27(8):1750-1754.
81. Kono K, Hayashi H, Takagishi T. 1994. Temperature-sensitive liposomes: Liposomes bearing poly (N-isopropylacrylamide). J Control Release 30(1):69-75.
82. Kopeček J. 2013. Polymer-drug conjugates: Origins, progress to date and future directions. Adv Drug Deliv Rev 65(1):49-59.
83. Kozissnik B, Bohorquez AC, Dobson J, Rinaldi C. 2013. Magnetic fluid hyperthermia: Advances, challenges, and opportunity. Int J Hyperthermia 29(8):706-714.
84. Krasnici S, Werner A, Eichhorn ME, Schmitt-Sody M, Pahernik SA, Sauer B, Schulze B, Teifel M, Michaelis U, Naujoks K, Dellian M. 2003. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer 105(4):561-567.
85. Kratz F. 2008. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J Control Release 132(3):171-183.
86. Kumar CSSR, Mohammad F. 2011. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev 63(9):789-808.
87. Lal S, Clare SE, Halas NJ. 2008. Nanoshell-enabled photothermal cancer therapy: Impending clinical impact. Acc Chem Res 41(12):1842-1851.
88. Lammers T, Kiessling F, Hennink WE, Storm G. 2012. Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress. J Control Release 161(2):175-187.
89. Landon CD, Park J-Y, Needham D, Dewhirst MW. 2011. Nanoscale drug delivery and hyperthermia: The materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer. Open Nanomed J 3:38-64.
90. Larson N, Gormley A, Frazier N, Ghandehari H. 2013. Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia. J Control Release 170(1):41-50.
91. Laurent S, Dutz S, Häfeli UO, Mahmoudi M. 2011. Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci 166(1-2):8-23.
92. Li B, Wang Q, Zou R, Liu X, Xu K, Li W, Hu J. 2014a. Cu7.2S4 nanocrystals: A novel photothermal agent with a 56.7% photothermal conversion efficiency for photothermal therapy of cancer cells. Nanoscale 6(6):3274-3282.
93. Li L, ten Hagen TLM, Bolkestein M, Gasselhuber A, Yatvin J, van Rhoon GC, Eggermont AMM, Haemmerich D, Koning GA. 2013. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia. J Control Release 167(2):130-137.
94. Li L, ten Hagen TLM, Haeri A, Soullié T, Scholten C, Seynhaeve ALB, Eggermont AMM, Koning GA. 2014b. A novel two-step mild hyperthermia for advanced liposomal chemotherapy. J Control Release 174(0):202-208.
95. Li L, ten Hagen TLM, Schipper D, Wijnberg TM, van Rhoon GC, Eggermont AMM, Lindner LH, Koning GA. 2010. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J Control Release 143(2):274-279.
96. Liehr AD. 1964. Interaction of electromagnetic radiation with matter. I. Theory of optical rotatory power: Topic A. Trigonal dihedral compounds1a. J Phys Chem 68(4):665-722.
97. Lindner U, Lawrentschuk N, Weersink RA, Davidson SRH, Raz O, Hlasny E, Langer DL, Gertner MR, Van der Kwast T, Haider MA. 2010. Focal laser ablation for prostate cancer followed by radical prostatectomy: Validation of focal therapy and imaging accuracy. Eur Urol 57(6):1111-1114.
98. Liu W, Dreher MR, Furgeson DY, Peixoto KV, Yuan H, Zalutsky MR, Chilkoti A. 2006. Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J Control Release 116(2):170-178.
99. Loo C, Lowery A, Halas N, West J, Drezek R. 2005. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 5(4):709-711.
100. Lynn JG, Zwemer RL, Chick AJ, Miller AE. 1942. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 26(2):179-193.
101. Maeda H. 2001. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189-207.
102. Maeda H, Nakamura H, Fang J. 2013. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev 65(1):71-79.
103. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 65(1-2):271-284.
104. Mamaeva V, Sahlgren C, Lindén M. 2013. Mesoporous silica nanoparticles in medicine-Recent advances. Adv Drug Deliv Rev 65(5):689-702.
105. Manzoor AA, Lindner LH, Landon CD, Park J-Y, Simnick AJ, Dreher MR, Das S, Hanna G, Park W, Chilkoti A, Koning GA, ten Hagen TLM, Needham D, Dewhirst MW. 2012. Overcoming limitations in nanoparticle drug delivery: Triggered, intravascular release to improve drug penetration into tumors. Cancer Res 72(21):5566-5575.
106. Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Part 1):6387-6392.
107. Mitragotri S, Stayton P. 2014. Organic nanoparticles for drug delivery and imaging. MRS Bull 39(03):219-223.
108. Miyata K, Christie RJ, Kataoka K. 2011. Polymeric micelles for nano-scale drug delivery. React Funct Polym 71(3):227-234.
109. Moon HK, Lee SH, Choi HC. 2009. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 3(11):3707-3713.
110. Moussa M, Goldberg SN, Kumar G, Sawant RR, Levchenko T, Torchilin VP, Ahmed M. 2014. Nanodrug-enhanced radiofrequency tumor ablation: Effect of micellar or liposomal carrier on drug delivery and treatment efficacy. PLoS ONE 9(8):102727.
111. Nakayama M, Okano T, Miyazaki T, Kohori F, Sakai K, Yokoyama M. 2006. Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. J Control Release 115(1):46-56.
112. Needham D, Anyarambhatla G, Kong G, Dewhirst MW. 2000. A New temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res 60(5):1197-1201.
113. Negussie AH, Miller JL, Reddy G, Drake SK, Wood BJ, Dreher MR. 2010. Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J Control Release 143(2):265-273.
114. Niidome T, Akiyama Y, Yamagata M, Kawano T, Mori T, Niidome Y, Katayama Y. 2009. Poly (ethylene glycol)-modified gold nanorods as a photothermal nanodevice for hyperthermia. J Biomater Sci Polym Ed 20(9):1203-1215.
115. Ninomiya K, Yamashita T, Kawabata S, Shimizu N. 2014. Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer. Ultrason Sonochem 21(4):1482-1488.
116. O'Connell MJ, Bachilo SM, Huffman CB, Moore VC, Strano MS, Haroz EH, Rialon KL, Boul PJ, Noon WH, Kittrell C, Ma J, Hauge RH, Weisman RB, Smalley RE. 2002. Band gap fluorescence from individual single-walled carbon nanotubes. Science 297(5581):593-596.
117. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. 2004. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 209(2):171-176.
118. Ojea-Jimenez I, Comenge J, Garcia-Fernandez L, Megson ZA, Casals E, Puntes VF. 2013. Engineered inorganic nanoparticles for drug delivery applications. Curr Drug Metabol 14(5):518-530.
119. O'Neill BE, Li KCP. 2008. Augmentation of targeted delivery with pulsed high intensity focused ultrasound. Int J Hyperthermia 24(6):506-520.
120. Patel PR, Luk A, Durrani A, Dromi S, Cuesta J, Angstadt M, Dreher MR, Wood BJ, Frenkel V. 2008. In vitro and in vivo evaluations of increased effective beam width for heat deposition using a split focus high intensity ultrasound (HIFU) transducer. Int J Hyperthermia 24(7):537-549.
121. Pernot M, Aubry JF, Tanter M, Thomas JL, Fink M. 2003. High power transcranial beam steering for ultrasonic brain therapy. Phys Med Biol 48(16):2577-2589.
122. Petryk AA, Stigliano RV, Giustini AJ, Gottesman RE, Trembly BS, Kaufman PA, Hoopes PJ. 2011. Comparison of iron oxide nanoparticle and microwave hyperthermia alone or combined with cisplatinum in murine breast tumors. Proceedings in SPIE (7901).
123. Pissuwan D, Niidome T, Cortie MB. 2011. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 149(1):65-71.
124. Pissuwan D, Valenzuela SM, Cortie MB. 2006. Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotechnol 24(2):62-67.
125. Ponce AM, Vujaskovic Z, Yuan F, Needham D, Dewhirst MW. 2006. Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 22(3):205-213.
126. Poon RTP, Borys N. 2009. Lyso-thermosensitive liposomal doxorubicin: A novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 10(2):333-343.
127. Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC. 2013. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 73(8):2412-2417.
128. Pradhan P, Giri J, Rieken F, Koch C, Mykhaylyk O, Döblinger M, Banerjee R, Bahadur D, Plank C. 2010. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release 142(1):108-121.
129. Puls R, Langner S, Rosenberg C, Hegenscheid K, Kuehn JP, Noeckler K, Hosten N. 2009. Laser ablation of liver metastases from colorectal cancer with mr thermometry: 5-year survival. J Vasc Interv Radiol 20(2):225-234.
130. Ranjan A, Jacobs GC, Woods DL, Negussie AH, Partanen A, Yarmolenko PS, Gacchina CE, Sharma KV, Frenkel V, Wood BJ, Dreher MR. 2012. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release 158(3):487-494.
131. Ribatti D, Nico B, Crivellato E, Vacca A. 2007. The structure of the vascular network of tumors. Cancer Lett 248(1):18-23.
132. Rosensweig RE. 2002. Heating magnetic fluid with alternating magnetic field. J Magn Magn Mater 252(0):370-374.
133. Sapra P, Allen TM. 2003. Ligand-targeted liposomal anticancer drugs. Prog Lipid Res 42(5):439-462.
134. Sherlock SP, Tabakman SM, Xie L, Dai H. 2011. Photothermally enhanced drug delivery by ultrasmall multifunctional feco/graphitic shell nanocrystals. ACS Nano 5(2):1505-1512.
135. Shetty A, Elliott AM, Schwartz JA, Wang J, Esparza-Coss E, Klumpp S, Taylor B, Hazle JD, Stafford RJ. 2008. Use of gold nanoshells to mediate heating induced perfusion changes in prostate tumors. Proceedings in SPIE (6842).
136. Shokouhimehr M, Soehnlen ES, Hao J, Griswold M, Flask C, Fan X, Basilion JP, Basu S, Huang SD. 2010. Dual purpose Prussian blue nanoparticles for cellular imaging and drug delivery: A new generation of T1-weighted MRI contrast and small molecule delivery agents. J Mater Chem 20(25):5251-5259.
137. Shrivastav S, Kaelin WG, Joines WT, Jirtle RL. 1983. Microwave hyperthermia and its effect on tumor blood flow in rats. Cancer Res 43(10):4665-4669.
138. Shubayev VI, Pisanic Ii TR, Jin S. 2009. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61(6):467-477.
139. Singh N, Jenkins GJS, Asadi R, Doak SH. 2010. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Reviews (1).
140. Smith B, Lyakhov I, Loomis K, Needle D, Baxa U, Yavlovich A, Capala J, Blumenthal R, Puri A. 2011. Hyperthermia-triggered intracellular delivery of anticancer agent to HER2+ cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2+ affisomes). J Control Release 153(2):187-194.
141. Song CW. 1984. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res 44(10 Supplement):4721s-4730s.
142. Song X, Gong H, Yin S, Cheng L, Wang C, Li Z, Li Y, Wang X, Liu G, Liu Z. 2014. Ultra-small iron oxide doped polypyrrole nanoparticles for in vivo multimodal imaging guided photothermal therapy. Adv Funct Mater 24(9):1194-1201.
143. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70(1-2):1-20.
144. Staves B. 2010. Pilot study of Aurolase™ therapy in refractory and/or recurrent tumors of the head and neck. http://clinicaltrials.gov/ct2/show/related/NCT00848042?term=auroshells&rank=1. Accessed April 23, 2015.
145. Stolik S, Delgado JA, Pérez A, Anasagasti L. 2000. Measurement of the penetration depths of red and near infrared light in human "ex vivo" tissues. J Photochem Photobiol B 57(2-3):90-93.
146. Strangman G, Boas DA, Sutton JP. 2002. Non-invasive neuroimaging using near-infrared light. Biol Psychiatry 52(7):679-693.
147. Sun C, Lee JSH, Zhang M. 2008. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 60(11):1252-1265.
148. Sun X, Zhang G, Keynton RS, O'Toole MG, Patel D, Gobin AM. 2013. Enhanced drug delivery via hyperthermal membrane disruption using targeted gold nanoparticles with PEGylated Protein-G as a cofactor. Nanomedicine 9(8):1214-1222.
149. Svenson S, Tomalia DA. 2012. Dendrimers in biomedical applications-reflections on the field. Advanced Drug Delivery Reviews. Supplement 64(0):102-115.
150. Ta T, Porter TM. 2013. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release 169(1-2):112-125.
151. Ter Haar GR. 2001. High intensity focused ultrasound for the treatment of tumors. Echocardiography 18(4):317-322.
152. Thiesen BA. 2008. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia 24(6):467-474.
153. Thomas J-L, Fink MA. 1996. Ultrasonic beam focusing through tissue inhomogeneities with a time reversal mirror: Application to transskull therapy. IEEE Trans Ultrason Ferroelectr Freq Control 43(6):1122-1129.
154. Tian Q, Jiang F, Zou R, Liu Q, Chen Z, Zhu M, Yang S, Wang J, Wang J, Hu J. 2011. Hydrophilic Cu9S5 nanocrystals: A photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo. ACS Nano 5(12):9761-9771.
155. Tian Q, Wang Q, Yao KX, Teng B, Zhang J, Yang S, Han Y. 2014. Multifunctional Polypyrrole@Fe3O4 nanoparticles for dual-modal imaging and in vivo photothermal cancer therapy. Small 10(6):1063-1068.
156. Torchilin VP. 2007. Micellar nanocarriers: Pharmaceutical perspectives. Pharm Res 24(1):1-16.
157. U.S. NIH. 2015. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/results?term=thermodox. Accessed April 23, 2015.
158. Veiseh O, Gunn JW, Zhang M. 2010. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 62(3):284-304.
159. Wei H, Cheng S-X, Zhang X-Z, Zhuo R-X. 2009. Thermo-sensitive polymeric micelles based on poly(N-isopropylacrylamide) as drug carriers. Prog Polym Sci 34(9):893-910.
160. Wei H, Zhang X-Z, Zhou Y, Cheng S-X, Zhuo R-X. 2006. Self-assembled thermoresponsive micelles of poly(N-isopropylacrylamide-b-methyl methacrylate). Biomaterials 27(9):2028-2034.
161. Wei S, Paul A, Mai Y, Laetitia R, Satya P. 2013. Carbon nanotubes for use in medicine: Potentials and limitations. In: Suzuki S, editor. Syntheses and applications of carbon nanotubes and their composites. Rijeka, Croatia: Intech. [Online access].
162. Weinstein JN, Magin RL, Yatvin MB, Zaharko DS. 1979. Liposomes and local hyperthermia: Selective delivery of methotrexate to heated tumors. Science 204(4389):188-191.
163. Weissleder R. 2001. A clearer vision for in vivo imaging. Nat Biotech 19(4):316-317.
164. Wu S-K, Chiang C-F, Hsu Y-H, Lin T-H, Liou H-C, Fu W-M, Lin W-L. 2014. Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer. Int J Nanomed 9:4485-4494.
165. Wust P, Gneveckow U, Johannsen M, Böhmer D, Henkel T, Kahmann F, Sehouli J, Felix R, Ricke J, Jordan A. 2006. Magnetic nanoparticles for interstitial thermotherapy-Feasibility, tolerance and achieved temperatures. Int J Hyperthermia 22(8):673-685.
166. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. 2002. Hyperthermia in combined treatment of cancer. Lancet Oncol 3(8):487-497.
167. Xu S, Olenyuk BZ, Okamoto CT, Hamm-Alvarez SF. 2013. Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances. Adv Drug Deliv Rev 65(1):121-138.
168. Yang K, Xu H, Cheng L, Sun CY, Wang J, Liu Z. 2012. In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv Mater 24(41):5586-5592.
169. Yatvin MB, Weinstein JN, Dennis WH, Blumenthal R. 1978. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202(4374):1290-1293.
170. Yokoyama M. 2011. Clinical applications of polymeric micelle carrier systems in chemotherapy and image diagnosis of solid tumors. J Exp Clin Med 3(4):151-158.
171. Zha Z, Yue X, Ren Q, Dai Z. 2013. Uniform polypyrrole nanoparticles with high photothermal conversion efficiency for photothermal ablation of cancer cells. Adv Mater 25(5):777-782.
172. Zhou Y-F. 2011. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol 2(1):8-27.